Subsequent Event |
12 Months Ended |
|---|---|
Dec. 31, 2016 | |
| Subsequent Events [Abstract] | |
| Subsequent Event | Subsequent Event On January 31, 2017, the company implemented a reduction in its workforce of approximately 100 associates. The company expects to incur pre-tax cash restructuring charges, primarily relating to severance and transition assistance, of approximately $2,200,000, that will be expensed in the first quarter of 2017. The company expects cash payments to be made from January 2017 through September 2017. Once this reduction in workforce is completed, the company expects that it will generate approximately $6,600,000 in annualized pre-tax savings. The restructuring is part of the company's three-phase business transformation from a generalist durable medical equipment company to one that focuses its strong technical capabilities on solving complex clinical needs for post-acute care. On February 2, 2017, the company repurchased all of the outstanding $13,350,000 principal amount of 4.125% Convertible Senior Subordinated Debentures due 2027 (the "debentures") as the holders exercised their February 1, 2017 right to require the company to repurchase their debentures, which were repurchased at 100% of the principal amount. As a result of the repurchase, no debentures remain outstanding, and the company wrote-off unamortized debt fees of $207,000 and recognized amortization expense of $311,000 in the first quarter of 2017. |